RxDoctor Payments Data

Justin Frey, MD

Family Medicine · Edgerton, WINPI 1164708004

Payments from drug & device makers

$623in general payments, 2019–2025

Across 35 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$135
  • Novo Nordisk$128
  • Pfizer$101
  • Lilly USA, LLC$56
  • Merck$36
  • Johnson & Johnson$33
  • plus $134 from 8 others

What the payments were for

  • Food & beverage$623100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$623 in reported general payments places this provider in the 80th percentile of 1,482 family medicine providers in Wisconsin.

See all family medicine providers in Wisconsin

Medicare billing

Part B allowed, 2024
$82,181
Medicare patients
277
Services billed
989

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide186$303,042
EliquisApixaban168$199,765
JardianceEmpagliflozin80$111,332
XareltoRivaroxaban43$65,809
TrulicityDulaglutide27$60,992
MounjaroTirzepatide39$55,056
Lantus SolostarInsulin Glargine,hum.Rec.Anlog118$27,384
LinzessLinaclotide14$20,180
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$19,883
Humalog Kwikpen U-100Insulin Lispro29$16,873
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate18$13,187
Atorvastatin Calcium966$9,973
SymbicortBudesonide/Formoterol Fumarate21$9,501
FarxigaDapagliflozin Propanediol13$8,730
Repatha SureclickEvolocumab15$8,187

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$128$303,042186 claims
PfizerEliquis, Paxlovid$101$205,397183 claims
Lilly USA, LLCTrulicity, Mounjaro$56$116,04866 claims
Boehringer IngelheimJardiance$12$111,33280 claims
Johnson & JohnsonXarelto$33$65,80943 claims
AstraZenecaSymbicort, Farxiga$17$18,23134 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,482 family medicine providers in Wisconsin.

Other family medicine in Edgerton

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →